Valspar today reported fiscal fourth-quarter earnings of $63.5 million, down 14% year-on-year (YOY), on sales up 8%, to $1.1 billion. Excluding restructuring charges, adjusted earnings totaled $86 million, or 97 cts/share, up 7.5% and beating analystsâ€™ consensus estimate of 92 cts/share, as reported by Thomson Reuters (New York). Valsparâ€™s fiscal fourth-quarter ended on 25 October. â€śThe fourth quarter was a good finish to the year, as growth in both sales and operating income improved from previous quarters. Sales growth was led by strong performance in our...
Access is for Chemweek 24/7 PLUS Members ONLY
This information is only available to Chemweek 24/7 PLUS members who have subscribed to Chemweek’s Business Daily. If you are a member, please log in, OR if you have a trial membership, please use your trial membership account information.
Forgot your user ID or password? Click here to have it sent to you.